MidEuropa, a leading private equity investor with deep roots in Central Europe, announces that its portfolio company, Diagnostyka, a leading provider of ...
Multi-strategy hedge funds are bigger than ever. Some who have worked for the biggest brands are now advising others on how ...
The authors write "we have recently seen intense activity in debt and equity transactions that finance the construction and acquisition of data centers. This strong investor appetite is expected to ...
Oncocyte (OCX) has entered into securities purchase agreements with existing investors for a registered direct offering and concurrent private ...
On July 30, 2024, BCI announced it entered into a definitive agreement to sell its majority stake in Hayfin to Arctos. All regulatory approvals have been secured, and the transaction was completed on ...
Gaven Cheong, the former head of investment funds and partner at PwC’s Hong Kong law firm affiliate Tiang & Partners, is ...
Dividend recapitalization, when a private company pays its investors a cash dividend with borrowed money, surged to a record ...
In the year ahead, private equity, exchange traded funds and tax-loss harvesting promise to be top priorities for advisors ...
U.S. private equity firm Bain Capital has bought Mitsubishi Tanabe Pharma in a deal worth 510 billion yen ($3.4 billion), ...
As private capital markets surged in recent years, the ability for private credit and private equity assets to seep into ...
Despite a rough environment, a growing pipeline of independent sponsors is expected to launch debut funds in coming years, ...
Japan's Mitsubishi Chemical said on Friday it will sell pharmaceutical unit Tanabe Mitsubishi Pharma to U.S. private equity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback